{"product_id":"a-practical-guide-to-vulval-disease-9781119146056","title":"A Practical Guide to Vulval Disease","description":"\u003cb\u003eBook Synopsis\u003c\/b\u003e\u003cbr\u003e\u003cb\u003eA PRACTICAL GUIDE TO VULVAL DISEASE DIAGNOSIS AND MANAGEMENT\u003c\/b\u003e \u003cp\u003e\u003cb\u003eA PRACTICAL GUIDE TO VULVAL DISEASE DIAGNOSIS AND MANAGEMENT\u003c\/b\u003e \u003c\/p\u003e\u003cp\u003ePatients with vulval disease frequently experience delays in diagnosis due to a lack of training for physicians. \u003ci\u003eA Practical Guide to Vulval Disease: Diagnosis and Management\u003c\/i\u003e offers practical, up-to-date and expert guidance on the diagnosis and management of vulval disorders. It provides the knowledge required for diagnosis and treatment of these conditions at both trainee and specialist level. Key information about diagnosis, investigation and basic management is included, with a section on signs and symptoms to direct the reader to the appropriate chapter for the particular disease. Current classification and terminology of vulval disease is featured, along with guidance on when a patient should be referred to a specialist. \u003c\/p\u003e\u003cp\u003eWell illustrated, with 185 high quality photographs, this user-friendly clinical guidebook integrates clinical a\u003cbr\u003e\u003cbr\u003e\u003cb\u003eTable of Contents\u003c\/b\u003e\u003cbr\u003e\u003c\/p\u003e\u003cp\u003eAcknowledgements xvii\u003c\/p\u003e \u003cp\u003e\u003cb\u003e1 The Normal Vulva 1\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eNormal Vulval Anatomy 1\u003c\/p\u003e \u003cp\u003eNormal Vulval and Vaginal Flora 4\u003c\/p\u003e \u003cp\u003eFurther Reading 4\u003c\/p\u003e \u003cp\u003eNormal Anatomical Variants 4\u003c\/p\u003e \u003cp\u003eNormal Changes Over the Lifetime 6\u003c\/p\u003e \u003cp\u003eChildhood 6\u003c\/p\u003e \u003cp\u003ePregnancy 6\u003c\/p\u003e \u003cp\u003eMenopause 6\u003c\/p\u003e \u003cp\u003eFurther Reading 7\u003c\/p\u003e \u003cp\u003e\u003cb\u003e2 Taking a History and Examination 9\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eTaking a History 9\u003c\/p\u003e \u003cp\u003eGeneral Medical History 9\u003c\/p\u003e \u003cp\u003eGynaecological History 10\u003c\/p\u003e \u003cp\u003eDermatological History 10\u003c\/p\u003e \u003cp\u003eVulval History 10\u003c\/p\u003e \u003cp\u003eExamination of the Vulva 11\u003c\/p\u003e \u003cp\u003eFurther Reading 13\u003c\/p\u003e \u003cp\u003e\u003cb\u003e3 How to Take a Vulval Biopsy and the Importance of Clinico‐Pathological Correlation 15\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eIncisional Biopsy 16\u003c\/p\u003e \u003cp\u003eFixation of the Biopsy 20\u003c\/p\u003e \u003cp\u003eFurther Reading 21\u003c\/p\u003e \u003cp\u003e\u003cb\u003e4 Basic Histology of the Vulva 23\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eSpecial Histological Stains 24\u003c\/p\u003e \u003cp\u003eImmunohistochemical Stains 26\u003c\/p\u003e \u003cp\u003eOther Tests 27\u003c\/p\u003e \u003cp\u003eFurther Reading 28\u003c\/p\u003e \u003cp\u003e\u003cb\u003e5 Investigations in Vulval Disease 29\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eInvestigations for Infection 29\u003c\/p\u003e \u003cp\u003eBacterial Swabs 29\u003c\/p\u003e \u003cp\u003eViral Swabs 29\u003c\/p\u003e \u003cp\u003eFungal Scrapings 29\u003c\/p\u003e \u003cp\u003eWood’s Light Examination 32\u003c\/p\u003e \u003cp\u003eSerological Tests 32\u003c\/p\u003e \u003cp\u003eInvestigations for Allergy 32\u003c\/p\u003e \u003cp\u003eRast Tests 32\u003c\/p\u003e \u003cp\u003ePrick Tests 32\u003c\/p\u003e \u003cp\u003ePatch Tests (see Chapter 9) 32\u003c\/p\u003e \u003cp\u003eInvestigations for Inflammatory Disease 33\u003c\/p\u003e \u003cp\u003eDirect Immunofluorescence 33\u003c\/p\u003e \u003cp\u003eIndirect Immunofluorescence 34\u003c\/p\u003e \u003cp\u003eImaging Investigations 34\u003c\/p\u003e \u003cp\u003eUseful Web Sites for Patient Information 34\u003c\/p\u003e \u003cp\u003eFurther Reading 34\u003c\/p\u003e \u003cp\u003e\u003cb\u003e6 Topical Treatment in Vulval Disease 35\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eIntroduction 35\u003c\/p\u003e \u003cp\u003eGeneral Principles 35\u003c\/p\u003e \u003cp\u003eLotions 35\u003c\/p\u003e \u003cp\u003eGels 36\u003c\/p\u003e \u003cp\u003eOintments 36\u003c\/p\u003e \u003cp\u003eCreams 36\u003c\/p\u003e \u003cp\u003ePastes 36\u003c\/p\u003e \u003cp\u003eTopical Treatments Used for Vulval Disease 36\u003c\/p\u003e \u003cp\u003eEmollient 37\u003c\/p\u003e \u003cp\u003eTopical Steroids 38\u003c\/p\u003e \u003cp\u003eAdverse Effects 38\u003c\/p\u003e \u003cp\u003eTopical Steroids in Pregnancy 41\u003c\/p\u003e \u003cp\u003eAntiseptics 41\u003c\/p\u003e \u003cp\u003eAntibacterials 42\u003c\/p\u003e \u003cp\u003eAntifungals 42\u003c\/p\u003e \u003cp\u003eBarriers 42\u003c\/p\u003e \u003cp\u003eOthers 42\u003c\/p\u003e \u003cp\u003ePodophyllotoxin 42\u003c\/p\u003e \u003cp\u003eImiquimod 42\u003c\/p\u003e \u003cp\u003eCalcineurin Inhibitors 43\u003c\/p\u003e \u003cp\u003eTar 44\u003c\/p\u003e \u003cp\u003eEmla ® 44\u003c\/p\u003e \u003cp\u003ePractice Points 44\u003c\/p\u003e \u003cp\u003eFurther Reading 44\u003c\/p\u003e \u003cp\u003eUseful Web Sites for Patient Information 44\u003c\/p\u003e \u003cp\u003e\u003cb\u003e7 Symptoms in Vulval Disease 45\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003ePruritis (Itch) 45\u003c\/p\u003e \u003cp\u003eCauses of Vulval Pruritis 46\u003c\/p\u003e \u003cp\u003eSoreness 46\u003c\/p\u003e \u003cp\u003ePain 47\u003c\/p\u003e \u003cp\u003eDyspareunia 48\u003c\/p\u003e \u003cp\u003eDischarge 48\u003c\/p\u003e \u003cp\u003eNo Symptoms 49\u003c\/p\u003e \u003cp\u003eUseful Web Site for Patient Information 49\u003c\/p\u003e \u003cp\u003e\u003cb\u003e8 Signs in Vulval Disease 51\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eDifferential Diagnosis Based on Appearance 51\u003c\/p\u003e \u003cp\u003eAlgorithms 51\u003c\/p\u003e \u003cp\u003eFurther Reading 56\u003c\/p\u003e \u003cp\u003e\u003cb\u003e9 Eczema, Allergy and the Vulva 57\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eSeborrhoeic Eczema 57\u003c\/p\u003e \u003cp\u003eIncidence 57\u003c\/p\u003e \u003cp\u003ePathophysiology 57\u003c\/p\u003e \u003cp\u003eSymptoms 58\u003c\/p\u003e \u003cp\u003eClinical Features 58\u003c\/p\u003e \u003cp\u003eBasic Management 58\u003c\/p\u003e \u003cp\u003eWhen to Refer 58\u003c\/p\u003e \u003cp\u003ePractice Points 59\u003c\/p\u003e \u003cp\u003eFurther Reading 59\u003c\/p\u003e \u003cp\u003eUseful Web Sites for Patient Information 59\u003c\/p\u003e \u003cp\u003eAllergic Contact Eczema \/ Dermatitis 59\u003c\/p\u003e \u003cp\u003eIntroduction 59\u003c\/p\u003e \u003cp\u003eIncidence 59\u003c\/p\u003e \u003cp\u003ePathophysiology 60\u003c\/p\u003e \u003cp\u003ePatch Testing (see Chapter 5) 60\u003c\/p\u003e \u003cp\u003eSymptoms 60\u003c\/p\u003e \u003cp\u003eClinical Features 60\u003c\/p\u003e \u003cp\u003eBasic Management 60\u003c\/p\u003e \u003cp\u003eWho to Refer for Patch Testing 60\u003c\/p\u003e \u003cp\u003ePractice Points 61\u003c\/p\u003e \u003cp\u003eFurther Reading 61\u003c\/p\u003e \u003cp\u003eUseful Web Sites for Patient Information 62\u003c\/p\u003e \u003cp\u003eIrritant Eczema \/ Dermatitis 62\u003c\/p\u003e \u003cp\u003eIntroduction 62\u003c\/p\u003e \u003cp\u003eIncidence 62\u003c\/p\u003e \u003cp\u003ePathophysiology 63\u003c\/p\u003e \u003cp\u003eHistological Features 63\u003c\/p\u003e \u003cp\u003eSymptoms 63\u003c\/p\u003e \u003cp\u003eClinical Features 63\u003c\/p\u003e \u003cp\u003eBasic Management 64\u003c\/p\u003e \u003cp\u003eWhen to Refer 64\u003c\/p\u003e \u003cp\u003ePractice Points 64\u003c\/p\u003e \u003cp\u003eFurther Reading 64\u003c\/p\u003e \u003cp\u003eUrticaria 64\u003c\/p\u003e \u003cp\u003eAllergic Contact Urticaria 64\u003c\/p\u003e \u003cp\u003eClinical Features 65\u003c\/p\u003e \u003cp\u003eManagement 65\u003c\/p\u003e \u003cp\u003eReferences 65\u003c\/p\u003e \u003cp\u003e\u003cb\u003e10 Psoriasis 67\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eIntroduction 67\u003c\/p\u003e \u003cp\u003eIncidence 67\u003c\/p\u003e \u003cp\u003ePathophysiology 67\u003c\/p\u003e \u003cp\u003eHistological Features 67\u003c\/p\u003e \u003cp\u003eSymptoms 68\u003c\/p\u003e \u003cp\u003eClinical Features 68\u003c\/p\u003e \u003cp\u003eBasic Management 69\u003c\/p\u003e \u003cp\u003eWhen to Refer 72\u003c\/p\u003e \u003cp\u003ePractice Points 73\u003c\/p\u003e \u003cp\u003eFurther Reading 73\u003c\/p\u003e \u003cp\u003eUseful Web Sites for Patient Information 73\u003c\/p\u003e \u003cp\u003e\u003cb\u003e11 Lichen Simplex 75\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eIntroduction 75\u003c\/p\u003e \u003cp\u003eEpidemiology 75\u003c\/p\u003e \u003cp\u003eIncidence 75\u003c\/p\u003e \u003cp\u003ePathophysiology 75\u003c\/p\u003e \u003cp\u003eHistological Features 76\u003c\/p\u003e \u003cp\u003eSymptoms 76\u003c\/p\u003e \u003cp\u003eClinical Features 76\u003c\/p\u003e \u003cp\u003eBasic Management 77\u003c\/p\u003e \u003cp\u003eWhen to Refer 78\u003c\/p\u003e \u003cp\u003ePractice Points 78\u003c\/p\u003e \u003cp\u003eFurther Reading 79\u003c\/p\u003e \u003cp\u003eUseful Web Sites for Patient Information 79\u003c\/p\u003e \u003cp\u003e\u003cb\u003e12 Lichen Sclerosus 81\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eIntroduction 81\u003c\/p\u003e \u003cp\u003eIncidence 81\u003c\/p\u003e \u003cp\u003ePathophysiology 81\u003c\/p\u003e \u003cp\u003eGenetic 82\u003c\/p\u003e \u003cp\u003eEpigenetics 82\u003c\/p\u003e \u003cp\u003eAutoimmunity 82\u003c\/p\u003e \u003cp\u003eHormonal Factors 82\u003c\/p\u003e \u003cp\u003eInfection 82\u003c\/p\u003e \u003cp\u003eTrauma 82\u003c\/p\u003e \u003cp\u003eRole of the Skin Immune System 82\u003c\/p\u003e \u003cp\u003eHistological Features 82\u003c\/p\u003e \u003cp\u003eSymptoms 83\u003c\/p\u003e \u003cp\u003eClinical Features 83\u003c\/p\u003e \u003cp\u003eAssociated Disease 90\u003c\/p\u003e \u003cp\u003eRisk of Malignancy 90\u003c\/p\u003e \u003cp\u003eBasic Management 92\u003c\/p\u003e \u003cp\u003eFollow Up 92\u003c\/p\u003e \u003cp\u003eWhen to Refer 92\u003c\/p\u003e \u003cp\u003ePractice Points 93\u003c\/p\u003e \u003cp\u003eFurther Reading 93\u003c\/p\u003e \u003cp\u003eUseful Web Sites for Patient Information 93\u003c\/p\u003e \u003cp\u003e\u003cb\u003e13 Lichen Planus 95\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eIntroduction 95\u003c\/p\u003e \u003cp\u003eEpidemiology 95\u003c\/p\u003e \u003cp\u003eIncidence 95\u003c\/p\u003e \u003cp\u003ePathophysiology 95\u003c\/p\u003e \u003cp\u003eHistological Features 96\u003c\/p\u003e \u003cp\u003eClinical Features of Lichen Planus 96\u003c\/p\u003e \u003cp\u003eVulval Lichen Planus 98\u003c\/p\u003e \u003cp\u003eClassic LP 98\u003c\/p\u003e \u003cp\u003eHypertrophic LP 98\u003c\/p\u003e \u003cp\u003eErosive LP 98\u003c\/p\u003e \u003cp\u003eRisk of Malignancy 99\u003c\/p\u003e \u003cp\u003eBasic Management 100\u003c\/p\u003e \u003cp\u003eWhen to Refer 101\u003c\/p\u003e \u003cp\u003ePractice Points 102\u003c\/p\u003e \u003cp\u003eFurther Reading 102\u003c\/p\u003e \u003cp\u003eUseful Web Sites for Patient Information 102\u003c\/p\u003e \u003cp\u003e\u003cb\u003e14 Hidradenitis Suppurativa and Crohn’s Disease 103\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eHidradenitis Suppurativa 103\u003c\/p\u003e \u003cp\u003eIntroduction 103\u003c\/p\u003e \u003cp\u003eEpidemiology 103\u003c\/p\u003e \u003cp\u003eIncidence 103\u003c\/p\u003e \u003cp\u003ePathophysiology 103\u003c\/p\u003e \u003cp\u003eHistological Features 103\u003c\/p\u003e \u003cp\u003eSymptoms 104\u003c\/p\u003e \u003cp\u003eClinical Features 104\u003c\/p\u003e \u003cp\u003eBasic Management 105\u003c\/p\u003e \u003cp\u003eMedical Management 105\u003c\/p\u003e \u003cp\u003eSurgery 105\u003c\/p\u003e \u003cp\u003eWhen to Refer 105\u003c\/p\u003e \u003cp\u003ePractice Points 106\u003c\/p\u003e \u003cp\u003eFurther Reading 106\u003c\/p\u003e \u003cp\u003eUseful Web Sites for Patient Information 106\u003c\/p\u003e \u003cp\u003eCrohn’s Disease 106\u003c\/p\u003e \u003cp\u003eIntroduction 106\u003c\/p\u003e \u003cp\u003eEpidemiology 106\u003c\/p\u003e \u003cp\u003ePathophysiology 107\u003c\/p\u003e \u003cp\u003eHistological Features 107\u003c\/p\u003e \u003cp\u003eSymptoms 107\u003c\/p\u003e \u003cp\u003eClinical Features 107\u003c\/p\u003e \u003cp\u003eBasic Management 109\u003c\/p\u003e \u003cp\u003eWhen to Refer 109\u003c\/p\u003e \u003cp\u003ePractice Points 109\u003c\/p\u003e \u003cp\u003eFurther Reading 110\u003c\/p\u003e \u003cp\u003eUseful Web Sites for Patient Information 110\u003c\/p\u003e \u003cp\u003e\u003cb\u003e15 Disorders of Pigmentation on the Vulva 111\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eIntroduction 111\u003c\/p\u003e \u003cp\u003ePostinflammatory Pigmentation 111\u003c\/p\u003e \u003cp\u003ePost‐Traumatic Pigmentation 111\u003c\/p\u003e \u003cp\u003eAcanthosis Nigricans 111\u003c\/p\u003e \u003cp\u003eManagement 113\u003c\/p\u003e \u003cp\u003eMelanosis 114\u003c\/p\u003e \u003cp\u003ePigmented Lesions 115\u003c\/p\u003e \u003cp\u003eHistory and Examination 115\u003c\/p\u003e \u003cp\u003eOther Techniques 116\u003c\/p\u003e \u003cp\u003eLentigines 116\u003c\/p\u003e \u003cp\u003eBenign Naevi 116\u003c\/p\u003e \u003cp\u003eAtypical Genital Naevi 117\u003c\/p\u003e \u003cp\u003eSeborrhoeic Keratoses 117\u003c\/p\u003e \u003cp\u003ePigmented Basal Cell Carcinoma 118\u003c\/p\u003e \u003cp\u003eHypopigmentation 118\u003c\/p\u003e \u003cp\u003eVitiligo 118\u003c\/p\u003e \u003cp\u003eWhen to Refer 119\u003c\/p\u003e \u003cp\u003ePractice Points 119\u003c\/p\u003e \u003cp\u003eFurther Reading 119\u003c\/p\u003e \u003cp\u003eUseful Web Sites for Patient Information 120\u003c\/p\u003e \u003cp\u003e\u003cb\u003e16 Other Dermatoses 121\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eGenetic Disorders 121\u003c\/p\u003e \u003cp\u003eHailey–Hailey Disease (Familial Benign Chronic Pemphigus) 121\u003c\/p\u003e \u003cp\u003eManagement 121\u003c\/p\u003e \u003cp\u003eWhen to Refer 121\u003c\/p\u003e \u003cp\u003ePractice Points 121\u003c\/p\u003e \u003cp\u003eFurther Reading 122\u003c\/p\u003e \u003cp\u003eUseful Web Site for Patient Information 122\u003c\/p\u003e \u003cp\u003eAuto‐Immune Bullous Disease 123\u003c\/p\u003e \u003cp\u003ePractice Points 126\u003c\/p\u003e \u003cp\u003eFurther Reading 126\u003c\/p\u003e \u003cp\u003eDrug Eruptions 126\u003c\/p\u003e \u003cp\u003eFixed Drug Eruption 126\u003c\/p\u003e \u003cp\u003eCommon Drugs Causing a Fixed Drug Eruption 126\u003c\/p\u003e \u003cp\u003eFurther Reading 126\u003c\/p\u003e \u003cp\u003eUseful Web Site for Patient Information 126\u003c\/p\u003e \u003cp\u003eStevens–Johnson Syndrome 127\u003c\/p\u003e \u003cp\u003eSymptoms 127\u003c\/p\u003e \u003cp\u003eClinical Features 127\u003c\/p\u003e \u003cp\u003eToxic Epidermal Necrolysis 127\u003c\/p\u003e \u003cp\u003eSymptoms 127\u003c\/p\u003e \u003cp\u003eClinical Features 127\u003c\/p\u003e \u003cp\u003eBasic Management 127\u003c\/p\u003e \u003cp\u003eFurther Reading 128\u003c\/p\u003e \u003cp\u003eUseful Web Site for Patient Information 128\u003c\/p\u003e \u003cp\u003eManifestations of Underlying Disease 128\u003c\/p\u003e \u003cp\u003eNecrolytic Migratory Erythema 128\u003c\/p\u003e \u003cp\u003eSymptoms 129\u003c\/p\u003e \u003cp\u003eClinical Features 129\u003c\/p\u003e \u003cp\u003eBasic Management 129\u003c\/p\u003e \u003cp\u003eFurther Reading 129\u003c\/p\u003e \u003cp\u003eAcrodermatitis Enteropathica 129\u003c\/p\u003e \u003cp\u003eClinical Features 129\u003c\/p\u003e \u003cp\u003eBasic Management 129\u003c\/p\u003e \u003cp\u003ePractice Point 130\u003c\/p\u003e \u003cp\u003eFurther Reading 130\u003c\/p\u003e \u003cp\u003eInflammatory Ulcers 130\u003c\/p\u003e \u003cp\u003eAphthous Ulcers 130\u003c\/p\u003e \u003cp\u003eClinical Features 130\u003c\/p\u003e \u003cp\u003eManagement 130\u003c\/p\u003e \u003cp\u003ePractice Point 130\u003c\/p\u003e \u003cp\u003eBehcet’s Syndrome 130\u003c\/p\u003e \u003cp\u003eFurther Reading 132\u003c\/p\u003e \u003cp\u003eUseful Resources 132\u003c\/p\u003e \u003cp\u003eLipschutz Ulceration 132\u003c\/p\u003e \u003cp\u003eClinical Features 132\u003c\/p\u003e \u003cp\u003eBasic Management 133\u003c\/p\u003e \u003cp\u003eFurther Reading 133\u003c\/p\u003e \u003cp\u003eOthers 133\u003c\/p\u003e \u003cp\u003eGraft‐Versus‐Host Disease 133\u003c\/p\u003e \u003cp\u003eFurther Reading 134\u003c\/p\u003e \u003cp\u003eZoon’s Vulvitis (Plasma Cell Vulvitis) 134\u003c\/p\u003e \u003cp\u003eHistology 134\u003c\/p\u003e \u003cp\u003eSymptoms 134\u003c\/p\u003e \u003cp\u003eClinical Features 135\u003c\/p\u003e \u003cp\u003eBasic Management 135\u003c\/p\u003e \u003cp\u003eFurther Reading 135\u003c\/p\u003e \u003cp\u003eVulvovaginal Adenosis 135\u003c\/p\u003e \u003cp\u003eFurther Reading 135\u003c\/p\u003e \u003cp\u003eLangerhans Cell Histiocytosis 136\u003c\/p\u003e \u003cp\u003eFurther Reading 136\u003c\/p\u003e \u003cp\u003e\u003cb\u003e17 Vulval Infection – Sexually Transmitted 137\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eNormal Flora 137\u003c\/p\u003e \u003cp\u003eTrichomoniasis 137\u003c\/p\u003e \u003cp\u003ePathophysiology 137\u003c\/p\u003e \u003cp\u003eClinical Features 138\u003c\/p\u003e \u003cp\u003eDiagnosis 138\u003c\/p\u003e \u003cp\u003eBasic Management 138\u003c\/p\u003e \u003cp\u003eFurther Reading 138\u003c\/p\u003e \u003cp\u003eUseful Web Sites for Patient Information 138\u003c\/p\u003e \u003cp\u003eChlamydia 139\u003c\/p\u003e \u003cp\u003eClinical Features 139\u003c\/p\u003e \u003cp\u003eDiagnosis 139\u003c\/p\u003e \u003cp\u003eTreatment 139\u003c\/p\u003e \u003cp\u003eFurther Reading 139\u003c\/p\u003e \u003cp\u003eUseful Web Site for Patient Information 139\u003c\/p\u003e \u003cp\u003eLymphogranuloma Venereum 139\u003c\/p\u003e \u003cp\u003eClinical Features 140\u003c\/p\u003e \u003cp\u003eDiagnosis 140\u003c\/p\u003e \u003cp\u003eTreatment 140\u003c\/p\u003e \u003cp\u003eFurther Reading 140\u003c\/p\u003e \u003cp\u003eUseful Web Site for Patient Information 140\u003c\/p\u003e \u003cp\u003eGonorrhoea 140\u003c\/p\u003e \u003cp\u003eClinical Features 140\u003c\/p\u003e \u003cp\u003eDiagnosis 140\u003c\/p\u003e \u003cp\u003eTreatment 141\u003c\/p\u003e \u003cp\u003eFurther Reading 141\u003c\/p\u003e \u003cp\u003eUseful Web Sites for Patient Information 141\u003c\/p\u003e \u003cp\u003eSyphilis 141\u003c\/p\u003e \u003cp\u003ePathophysiology 141\u003c\/p\u003e \u003cp\u003eClinical Features 141\u003c\/p\u003e \u003cp\u003eTreatment 142\u003c\/p\u003e \u003cp\u003eFurther Reading 142\u003c\/p\u003e \u003cp\u003eUseful Web Site for Patient Information 142\u003c\/p\u003e \u003cp\u003eChancroid 142\u003c\/p\u003e \u003cp\u003ePathophysiology 142\u003c\/p\u003e \u003cp\u003eClinical Features 143\u003c\/p\u003e \u003cp\u003eTreatment 143\u003c\/p\u003e \u003cp\u003eFurther Reading 143\u003c\/p\u003e \u003cp\u003eUseful Web Sites for Patient Information 143\u003c\/p\u003e \u003cp\u003eDonovanosis (Granuloma Inguinale) 143\u003c\/p\u003e \u003cp\u003eClinical Features 143\u003c\/p\u003e \u003cp\u003eDiagnosis 143\u003c\/p\u003e \u003cp\u003eTreatment 143\u003c\/p\u003e \u003cp\u003eFurther Reading 144\u003c\/p\u003e \u003cp\u003eUseful Web Site for Patient Information 144\u003c\/p\u003e \u003cp\u003eHerpes Simplex Infection 144\u003c\/p\u003e \u003cp\u003eIncidence 144\u003c\/p\u003e \u003cp\u003ePathophysiology 144\u003c\/p\u003e \u003cp\u003eClinical Features 144\u003c\/p\u003e \u003cp\u003eDifferential Diagnosis 145\u003c\/p\u003e \u003cp\u003eDiagnosis 146\u003c\/p\u003e \u003cp\u003eBasic Management 146\u003c\/p\u003e \u003cp\u003eHsv Infection and Pregnancy 146\u003c\/p\u003e \u003cp\u003eFurther Reading 147\u003c\/p\u003e \u003cp\u003eUseful Web Sites for Patient Information 147\u003c\/p\u003e \u003cp\u003eHuman Papillomavirus Infection 147\u003c\/p\u003e \u003cp\u003eEpidemiology 147\u003c\/p\u003e \u003cp\u003ePathophysiology 148\u003c\/p\u003e \u003cp\u003eThe Concept of Vulval Subclinical Lesion 148\u003c\/p\u003e \u003cp\u003eHistology 148\u003c\/p\u003e \u003cp\u003eClinical Features 149\u003c\/p\u003e \u003cp\u003eDiagnosis 149\u003c\/p\u003e \u003cp\u003eTreatment 150\u003c\/p\u003e \u003cp\u003eHpv Vaccine 150\u003c\/p\u003e \u003cp\u003eGenital Warts in Children 150\u003c\/p\u003e \u003cp\u003eFurther Reading 150\u003c\/p\u003e \u003cp\u003eUseful Web Sites for Patient Information 150\u003c\/p\u003e \u003cp\u003eMolluscum Contagiosum 150\u003c\/p\u003e \u003cp\u003eSymptoms 151\u003c\/p\u003e \u003cp\u003eClinical Appearance 151\u003c\/p\u003e \u003cp\u003eDiagnosis 151\u003c\/p\u003e \u003cp\u003eTreatment 151\u003c\/p\u003e \u003cp\u003eFurther Reading 152\u003c\/p\u003e \u003cp\u003eUseful Web Site for Patient Information 152\u003c\/p\u003e \u003cp\u003eScabies 152\u003c\/p\u003e \u003cp\u003eClinical Features 152\u003c\/p\u003e \u003cp\u003eDiagnosis 152\u003c\/p\u003e \u003cp\u003eTreatment 153\u003c\/p\u003e \u003cp\u003eFurther Reading 153\u003c\/p\u003e \u003cp\u003eUseful Web Site for Patient Information 153\u003c\/p\u003e \u003cp\u003ePubic Lice 153\u003c\/p\u003e \u003cp\u003eClinical Features 153\u003c\/p\u003e \u003cp\u003eTreatment 153\u003c\/p\u003e \u003cp\u003eUseful Web Site for Patient Information 153\u003c\/p\u003e \u003cp\u003e\u003cb\u003e18 Vulval Infection – Nonsexually Transmitted 155\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eBacterial Infections 155\u003c\/p\u003e \u003cp\u003eBacterial Vaginosis 155\u003c\/p\u003e \u003cp\u003eClinical Features 155\u003c\/p\u003e \u003cp\u003eDiagnosis 155\u003c\/p\u003e \u003cp\u003eTreatment 155\u003c\/p\u003e \u003cp\u003eFurther Reading 157\u003c\/p\u003e \u003cp\u003eUseful Web Sites for Patient Information 157\u003c\/p\u003e \u003cp\u003eErythrasma 157\u003c\/p\u003e \u003cp\u003eClinical Features 157\u003c\/p\u003e \u003cp\u003eDifferential Diagnosis 157\u003c\/p\u003e \u003cp\u003eDiagnosis 158\u003c\/p\u003e \u003cp\u003eBasic Management 158\u003c\/p\u003e \u003cp\u003eUseful Web Site for Patient Information 158\u003c\/p\u003e \u003cp\u003eStaphylococcal and Streptococcal Infections 158\u003c\/p\u003e \u003cp\u003eFolliculitis 159\u003c\/p\u003e \u003cp\u003ePathophysiology 159\u003c\/p\u003e \u003cp\u003eClinical Features 159\u003c\/p\u003e \u003cp\u003eDiagnosis 159\u003c\/p\u003e \u003cp\u003eBasic Management 159\u003c\/p\u003e \u003cp\u003eFurther Reading 159\u003c\/p\u003e \u003cp\u003eBartholin Abscess 159\u003c\/p\u003e \u003cp\u003eClinical Features 160\u003c\/p\u003e \u003cp\u003eDifferential Diagnosis 160\u003c\/p\u003e \u003cp\u003eBasic Management 160\u003c\/p\u003e \u003cp\u003eDrainage of the Abscess 160\u003c\/p\u003e \u003cp\u003eMarsupialization 160\u003c\/p\u003e \u003cp\u003eFurther Reading 160\u003c\/p\u003e \u003cp\u003eOther Staphylococcal Infections 161\u003c\/p\u003e \u003cp\u003eToxic Shock Syndrome 161\u003c\/p\u003e \u003cp\u003eStaphylococcal Scalded Skin Syndrome 161\u003c\/p\u003e \u003cp\u003eCellulitis 161\u003c\/p\u003e \u003cp\u003eClinical Features 161\u003c\/p\u003e \u003cp\u003eDiagnosis 161\u003c\/p\u003e \u003cp\u003eDifferential Diagnosis 161\u003c\/p\u003e \u003cp\u003eOther Streptococcal Infections 161\u003c\/p\u003e \u003cp\u003eFurther Reading 162\u003c\/p\u003e \u003cp\u003eVulvovaginal Candidiasis 162\u003c\/p\u003e \u003cp\u003ePathophysiology 162\u003c\/p\u003e \u003cp\u003eClinical Features 163\u003c\/p\u003e \u003cp\u003eDifferential Diagnosis 163\u003c\/p\u003e \u003cp\u003eDiagnosis 164\u003c\/p\u003e \u003cp\u003eTreatment 164\u003c\/p\u003e \u003cp\u003eFurther Reading 164\u003c\/p\u003e \u003cp\u003eUseful Web Sites for Patient Information 164\u003c\/p\u003e \u003cp\u003eTinea Cruris 165\u003c\/p\u003e \u003cp\u003ePathophysiology 165\u003c\/p\u003e \u003cp\u003eClinical Features 165\u003c\/p\u003e \u003cp\u003eDifferential Diagnosis 165\u003c\/p\u003e \u003cp\u003eDiagnosis 166\u003c\/p\u003e \u003cp\u003eBasic Management 166\u003c\/p\u003e \u003cp\u003eFurther Reading 166\u003c\/p\u003e \u003cp\u003eUseful Web Site for Patient Information 166\u003c\/p\u003e \u003cp\u003eViral Infections 166\u003c\/p\u003e \u003cp\u003eVaricella Zoster (Shingles) 166\u003c\/p\u003e \u003cp\u003e\u003cb\u003e19 Vulval Intraepithelial Neoplasia 167\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eIntroduction 167\u003c\/p\u003e \u003cp\u003eEpidemiology 167\u003c\/p\u003e \u003cp\u003eAetiology 168\u003c\/p\u003e \u003cp\u003ePrevention 168\u003c\/p\u003e \u003cp\u003eHistological Features 168\u003c\/p\u003e \u003cp\u003eSymptoms 169\u003c\/p\u003e \u003cp\u003eClinical Features 169\u003c\/p\u003e \u003cp\u003eManagement 173\u003c\/p\u003e \u003cp\u003eProgression 174\u003c\/p\u003e \u003cp\u003eMelanoma in situ 176\u003c\/p\u003e \u003cp\u003eWhen to Refer 176\u003c\/p\u003e \u003cp\u003ePractice Points 176\u003c\/p\u003e \u003cp\u003eFurther Reading 177\u003c\/p\u003e \u003cp\u003eUseful Web Site for Patient Information 177\u003c\/p\u003e \u003cp\u003e\u003cb\u003e20 Extramammary Paget’s Disease 179\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eIntroduction 179\u003c\/p\u003e \u003cp\u003eEpidemiology 179\u003c\/p\u003e \u003cp\u003eHistological Features 179\u003c\/p\u003e \u003cp\u003eClassification 180\u003c\/p\u003e \u003cp\u003eSymptoms 181\u003c\/p\u003e \u003cp\u003eClinical Features 181\u003c\/p\u003e \u003cp\u003eManagement 183\u003c\/p\u003e \u003cp\u003eRecurrences 185\u003c\/p\u003e \u003cp\u003eProgression 185\u003c\/p\u003e \u003cp\u003eFollow Up 186\u003c\/p\u003e \u003cp\u003eWhen to Refer 186\u003c\/p\u003e \u003cp\u003ePractice Points 186\u003c\/p\u003e \u003cp\u003eFurther Reading 186\u003c\/p\u003e \u003cp\u003eUseful Web Site for Patient Information 187\u003c\/p\u003e \u003cp\u003e\u003cb\u003e21 Vulval Squamous Cell Carcinoma 189\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eIntroduction 189\u003c\/p\u003e \u003cp\u003eEpidemiology 189\u003c\/p\u003e \u003cp\u003eAetiology \/ Histology 189\u003c\/p\u003e \u003cp\u003eSymptoms and Clinical Features 190\u003c\/p\u003e \u003cp\u003eManagement 190\u003c\/p\u003e \u003cp\u003eSurgery 190\u003c\/p\u003e \u003cp\u003eComplications 191\u003c\/p\u003e \u003cp\u003eRadiotherapy 192\u003c\/p\u003e \u003cp\u003eFollow Up 193\u003c\/p\u003e \u003cp\u003ePrognosis 193\u003c\/p\u003e \u003cp\u003eWhen to Refer 193\u003c\/p\u003e \u003cp\u003ePractice Points 193\u003c\/p\u003e \u003cp\u003eFurther Reading 194\u003c\/p\u003e \u003cp\u003eUseful Web Site for Patient Information 194\u003c\/p\u003e \u003cp\u003e\u003cb\u003e22 Other Vulval Cancers 195\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eBasal Cell Carcinoma 195\u003c\/p\u003e \u003cp\u003eEpidemiology 195\u003c\/p\u003e \u003cp\u003eIncidence 195\u003c\/p\u003e \u003cp\u003ePathophysiology 195\u003c\/p\u003e \u003cp\u003eHistological Features 195\u003c\/p\u003e \u003cp\u003eSymptoms 196\u003c\/p\u003e \u003cp\u003eClinical Features 196\u003c\/p\u003e \u003cp\u003eBasic Management 196\u003c\/p\u003e \u003cp\u003eWhen to Refer 196\u003c\/p\u003e \u003cp\u003ePractice Points 197\u003c\/p\u003e \u003cp\u003eFurther Reading 197\u003c\/p\u003e \u003cp\u003eUseful Web Site for Patient Information 197\u003c\/p\u003e \u003cp\u003eMalignant Melanoma 197\u003c\/p\u003e \u003cp\u003eEpidemiology 198\u003c\/p\u003e \u003cp\u003ePathophysiology 198\u003c\/p\u003e \u003cp\u003eHistological Features 198\u003c\/p\u003e \u003cp\u003eSymptoms 198\u003c\/p\u003e \u003cp\u003eClinical Features 198\u003c\/p\u003e \u003cp\u003eBasic Management 198\u003c\/p\u003e \u003cp\u003eFurther Reading 199\u003c\/p\u003e \u003cp\u003eOther Malignant Tumours and the Vulva 200\u003c\/p\u003e \u003cp\u003eFurther Reading 200\u003c\/p\u003e \u003cp\u003e\u003cb\u003e23 Vulvodynia 201\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eDefinition 201\u003c\/p\u003e \u003cp\u003eEpidemiology 201\u003c\/p\u003e \u003cp\u003ePathophysiology 203\u003c\/p\u003e \u003cp\u003ePsychological Aspects of Vulvodynia 203\u003c\/p\u003e \u003cp\u003eHistology 204\u003c\/p\u003e \u003cp\u003eSymptoms 204\u003c\/p\u003e \u003cp\u003eSigns 204\u003c\/p\u003e \u003cp\u003eDiagnosis 205\u003c\/p\u003e \u003cp\u003eManagement 205\u003c\/p\u003e \u003cp\u003eLocal Topical Pain Modifiers 205\u003c\/p\u003e \u003cp\u003eSystemic Pain Modifiers 205\u003c\/p\u003e \u003cp\u003ePhysical Therapy 206\u003c\/p\u003e \u003cp\u003ePsychosexual Therapy 207\u003c\/p\u003e \u003cp\u003eSurgical Treatment 207\u003c\/p\u003e \u003cp\u003eFurther Reading 207\u003c\/p\u003e \u003cp\u003eUseful Web Sites for Patient Information 207\u003c\/p\u003e \u003cp\u003e\u003cb\u003e24 Psychosexual Aspects of Vulval Disease 209\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eClinical Psychological Assessment 210\u003c\/p\u003e \u003cp\u003eFurther Reading 210\u003c\/p\u003e \u003cp\u003e\u003cb\u003e25 Benign Lesions 211\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eEpidermoid Cysts 211\u003c\/p\u003e \u003cp\u003eComedones 211\u003c\/p\u003e \u003cp\u003eSyringomata 211\u003c\/p\u003e \u003cp\u003eHidradenoma Papilliferum 213\u003c\/p\u003e \u003cp\u003eLymphangioma \/ Lymphangiectasia 214\u003c\/p\u003e \u003cp\u003eFurther Reading 214\u003c\/p\u003e \u003cp\u003eIndex 215\u003c\/p\u003e","brand":"John Wiley and Sons Ltd","offers":[{"title":"Default Title","offer_id":49406996513111,"sku":"9781119146056","price":97.16,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0817\/1739\/5799\/files\/9781119146056.jpg?v=1730497827","url":"https:\/\/bookcurl.com\/products\/a-practical-guide-to-vulval-disease-9781119146056","provider":"Book Curl","version":"1.0","type":"link"}